Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Warts 2Hyperthermia 2Breast Neoplasms 2Carcinoma, Basal Cell 1

Interventions

HhAntag691 14Biopsy 8Imiquimod 7Aminolevulinic Acid 7sonidegib 6Tomography, Optical Coherence 6Surgical Procedures, Operative 6Photochemotherapy 6Mohs Surgery 61-phenyl-3,3-dimethyltriazene 6Radiotherapy 5Itraconazole 5Nivolumab 4Microscopy, Confocal 4Curettage 4pembrolizumab 3methyl 5-aminolevulinate 3cemiplimab 3Standard of Care 3Niacinamide 3tazarotene 2relatlimab 2X-Rays 2Watchful Waiting 2Specimen Handling 2Observation 2Magnetic Resonance Spectroscopy 2Laser Therapy 2Gene Expression Profiling 2Eflornithine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Basal Cell × Hydrogen Peroxide × Clear all
NCT04929535 2022-08-30

Hydrogen Peroxide Trial to Investigate the Efficacy of 30%H2O2 as a Topical Application Before Definitive Treatment

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 2 Unknown
51 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡